The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
New Bibenzyl Cannabinoid from the New Zealand Liverwort Radula marginata
|
|---|---|
| Published in |
Chemical and Pharmaceutical Bulletin, January 2002
|
| DOI | 10.1248/cpb.50.1390 |
| Pubmed ID | |
| Authors |
Masao Toyota, Takuji Shimamura, Hikari Ishii, Matt Renner, John Braggins, Yoshinori Asakawa |
| Abstract |
The ether extract of the New Zealand liverwort Radula marginata afforded a new cannabinoid type bibenzyl compound named perrottetinenic acid, and two new bibenzyls, together with a known cannabinoid, perrottetinene. Their structures were established by two dimensional (2D) NMR spectral data. The structure of perrottetinenic acid was a similar to that of Delta(1)-tetrahydrocannabinol, a known hallucinogen. Cannabinoid type bibenzyls have been isolated from liverwort Radula perrottetii, though have not previously been reported from the liverwort R. marginata. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 1 | 25% |
| Japan | 1 | 25% |
| Unknown | 2 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 75% |
| Scientists | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 81 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 2% |
| Mexico | 1 | 1% |
| Unknown | 78 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 16 | 20% |
| Researcher | 15 | 19% |
| Student > Bachelor | 11 | 14% |
| Student > Master | 8 | 10% |
| Student > Postgraduate | 4 | 5% |
| Other | 11 | 14% |
| Unknown | 16 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 18 | 22% |
| Biochemistry, Genetics and Molecular Biology | 16 | 20% |
| Chemistry | 11 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 6% |
| Medicine and Dentistry | 4 | 5% |
| Other | 6 | 7% |
| Unknown | 21 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 March 2023.
All research outputs
#1,541,230
of 23,477,147 outputs
Outputs from Chemical and Pharmaceutical Bulletin
#6
of 5,757 outputs
Outputs of similar age
#2,551
of 124,673 outputs
Outputs of similar age from Chemical and Pharmaceutical Bulletin
#1
of 118 outputs
Altmetric has tracked 23,477,147 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,757 research outputs from this source. They receive a mean Attention Score of 4.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 124,673 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 118 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.